This week there have been two significant steps on the route for the Rare Cancers Bill becoming the Rare Cancers Act and next week is one of great significance too.
The Rare Cancers Bill is a Private Members Bill bought forward by Dr Scott Arthur MP and is aimed at improving outcomes for people with rare cancers through research, clinical trials, regulatory review and the naming of a national speciality lead.
Brain Tumour Research has been supporting Dr Arthur with his work on this from the very outset.
On Monday (30th June), the Bill took a major step forward as the UK Government confirmed the funding needed for it to progress. Then today, the Bill eased through it’s Committee Stage with no amendments requested. Once again Minister Dalton was there to personally, and on behalf of the Government, state support for the Bill. Pictured above are the members of today’s Committee.
Next week Brain Tumour Research will be part of a team promoting the Bill to the pharmaceutical industry, to other charities with a rare cancer focus, and at a drop in event at the House of Lords. On Friday 11th July, the Bill receives its third reading in the Commons and then barring an extraordinary turn of events it will then cross for scrutiny in the House of Lords.
To keep up to date with the progress of the Rare Cancers Bill sign up to receive our Weekly Campaigning Update.
Related reading:
